GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system.
Saved in:
| Title: | GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system. |
|---|---|
| Authors: | Fernández-Rilo AC; Research Area of Onco-haematology and Pharmaceutical GMP Facility, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., de Billy E; Research Area of Onco-haematology and Pharmaceutical GMP Facility, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.; Università Cattolica del Sacro Cuore, and Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy., Del Baldo G; Research Area of Onco-haematology and Pharmaceutical GMP Facility, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., De Angelis B; Research Area of Onco-haematology and Pharmaceutical GMP Facility, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Rossi S; Pathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Del Bufalo F; Research Area of Onco-haematology and Pharmaceutical GMP Facility, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Quintarelli C; Research Area of Onco-haematology and Pharmaceutical GMP Facility, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.; Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy., Locatelli F; Research Area of Onco-haematology and Pharmaceutical GMP Facility, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.; Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Italy., Mastronuzzi A; Research Area of Onco-haematology and Pharmaceutical GMP Facility, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Vinci M; Research Area of Onco-haematology and Pharmaceutical GMP Facility, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy. maria.vinci@opbg.net. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2025 Aug 21; Vol. 9 (1), pp. 295. Date of Electronic Publication: 2025 Aug 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-025-01079-1 |
